nanotechnology, nanotechnology links, nanomaterials, nanomaterial database, nanotechnology news
Nanowerk article print Printer-friendly
Nanowerk article email E-mail this article
Nanowerk news digest Daily News Email Digest
Subscribe to Nanowerk Spotlight Subscribe to Spotlight
Nanowerk on Facebook Join us on Facebook
Nanowerk on Twitter Follow us on Twitter
Nanowerk News Feeds Nanowerk News Feeds
Bookmark Nanowerk Story
Nanotechnology Top 10 Articles
Posted: Nov 19th, 2009
Posted: Nov 18th, 2009
Posted: Nov 17th, 2009
Posted: Nov 16th, 2009
Posted: Nov 12th, 2009
Posted: Nov 10th, 2009
Posted: Nov 9th, 2009
Posted: Nov 5th, 2009
Posted: Nov 4th, 2009
Posted: Nov 3rd, 2009
Posted: Nov 2nd, 2009
Posted: Oct 30th, 2009
Posted: Oct 28th, 2009
Posted: Oct 27th, 2009
Posted: Oct 26th, 2009
Posted: Oct 23rd, 2009
Posted: Oct 22nd, 2009
Posted: Oct 21st, 2009
Posted: Oct 16th, 2009
Posted: Oct 14th, 2009
Posted: Oct 13th, 2009
Posted: Oct 12th, 2009
Posted: Oct 9th, 2009
Posted: Oct 8th, 2009
Posted: Oct 7th, 2009
Posted: Oct 6th, 2009
Posted: Oct 5th, 2009
Posted: Oct 2nd, 2009
Posted: Oct 1st, 2009
Posted: Sep 30th, 2009
Posted: Sep 29th, 2009
Posted: Sep 28th, 2009
Posted: Sep 24th, 2009
Posted: Sep 22nd, 2009
Posted: Sep 18th, 2009
Posted: Sep 16th, 2009
Posted: Sep 15th, 2009
Posted: Sep 11th, 2009
Posted: Sep 9th, 2009
Posted: Sep 8th, 2009
...more nanotechnology articles
 
Posted: January 9, 2009
Nanotechnology safety for success dialogue
(Nanowerk Spotlight) Stakeholders attending the second annual "Safety for Success" dialogue last October in Brussels agreed that while many activities had taken place during the past year towards the responsible development and regulation of nanotechnologies more effort was needed. Discussion highlighted three areas that require coordinated effort from all parties: 1) Developing trustworthy information on products containing nanomaterials that are on or near the market, and on how they are tested. 2) Meaningful public engagement on the basis of shared definitions of nanotechnology. 3) Ongoing regulatory reviews to provide clear guidance to industry on how to interpret regulatory frameworks, and clear indications to the public about action being taken in cases where relevant risk data is limited or uncertain. In addition, the meeting identified a number of key points that need to be addressed in order to meet these three priorities.
nanotechnology safety for success
Further research on nanotechnology risks remains a significant priority. This work should include developing practical methodologies for testing nanomaterials. For example, more work is required to make reliable comparisons of in vitro and in vivo toxicology studies. Further work is needed on exposure routes and effects of longterm exposures to low dosages.
In addition, more knowledge is needed about nanomaterials in the environment, including questions of aggregation and disaggregation, accumulation, and interactions with other chemicals.
In the area of regulation, further clarification is requested regarding the adequacy of current regulation given uncertainties about the characterization and biological properties of nanomaterials. The meeting discussed developing regulatory options for pre-market intervention (assessment and authorization processes) including the question of considering nanomaterials as ‘new’ substances.
Finally, work is required on the introduction of post-market monitoring systems and consideration of the question of labeling.
The meeting requested that industry make information on safety aspects of nanotechnology containing products more accessible to regulators and consumers. While industry has engaged in several public dialogue processes in recent years further effort is needed to ensure that these are visible, well co-ordinated and lead to meaningful action.
Many participants agreed that positive steps had been taken during the past year. However, the overarching question remained how to ensure public confidence in efforts by all stakeholders to provide relevant information, develop appropriate testing methods, deal with remaining questions of uncertainty over risks, and appropriately implement regulatory frameworks.
The workshop was organized into sessions, each of which featured several presentations:
Session 1: Science and risk assessment

Latest developments in nanotoxicology pdf(1.4MB)

Prof. Günter Oberdörster, University of Rochester

Issues linked to carbon nanotubespdf(765KB)

Ken Donaldson, University of Edinburgh

From non-food to food risk assessmentspdf(450KB)

Dr. Wim de Jong, Dutch National Institute for Public Health and the Environment (RIVM)

Nanomaterials and the environmentpdf(1.8MB)

Prof. Teresa Fernandes, Napier University

The European commitment to nano safety researchpdf(290KB)

Ms. Pilar Aguar-Fernandez, European Commission, DG Research

Session 2: Regulation

Regulatory challenges of nanotechnologiespdf(700KB)

Prof. Graeme Hodge, Monash University, Melbourne

Regulatory aspects of nanotechnologies in the EUpdf(140KB)

Mr. Cornelis Brekelmans, >European Commission, DG Enterprise

A societal perspective on regulationpdf(135KB)

Ms. Laura Degallaix, BEUC - the European Consumers' Organisation

Session 3: International developments

International safety assessment of nanomaterialspdf(165KB)

Dr. Jim Willis, US Environmental Protection Agency

International monitoring of nanotechnologiespdf(1.2MB)

Dr. Robert G. Rudnitsky, US State Department

International standardspdf(530KB)

Dr. Peter Hatto, IonBond Ltd.

Session 4: Risk governance, communication, and perception

Risk governancepdf(500KB)

Prof. Ortwin Renn, University of Stuttgart

Risk communicationpdf(485KB)

Dr. Jørgen Schlundt, WHO, INFOSAN

Risk perceptionpdf(80KB)

Prof. James Hammitt, Harvard University School of Public Health

Session 5: Communication with the customer

Enabling Responsible Innovations of Nanotechnologies: European Chemical Industry’s Strategy on Nanomaterials and Nanotechnologiespdf(165KB)

Mrs Jenny Holmqvist, European Chemical Industry Council (CEFIC)

Communicating business-to-business product informationpdf(240KB)

Dr. Markus Pridoehl, Evonik

Communicating business-to-consumers product informationpdf(565KB)

Ms. Karolyn Kranz, BASF

Consumer expectations on product informationpdf(70KB)

Mr Michael Hansen, Consumers Union

Session 6: Highlights from the participant survey on communication, legislation, and its implementation
Session 7: "Introduction to the discussion on the implementation of the existing legislation: Examples from the chemical, medical, and food areas"

Guidance in the chemicals areapdf(670KB)

Dr. Peter van der Zandt, European Commission, DG Environment

Guidance in the medical areapdf(335KB)

Dr Marisa Papaluca-Amati, EMEA

Guidance in the food area pdf(670KB)

Dr. David Carlander, EFSA

Session 8: "Identification in break-out groups of means to improve (i) communication and (ii) the implementation of the existing legislation in the chemical, medical, products, and food areas (priorities and next steps, for whom and when)"

Recommendations of breakout group 1: Chemicalspdf(130KB)

Recommendations of breakout group 2: Medicinespdf(180KB)

Recommendations of breakout group 3: Productspdf(165KB)

Recommendations of breakout group 4: Food=pdf(170KB)

A copy of the entire workshop report, including a summary of the discussions is also available as a pdf download (264 KB).
By Michael Berger, Copyright 2009 Nanowerk LLC
Bookmark Nanowerk Directory
Subscribe! Receive a convenient email notification whenever a new Nanowerk Nanotechnology Spotlight posts.
Become a Spotlight guest author! Have you just published a scientific paper or have other exciting developments to share with the nanotechnology community? Let us know.
 
 
 
Privacy statement | Terms of use | Contact us | Home | Sitemap | Advertise with us
The contents of this site are copyright ©2009, Nanowerk LLC. All Rights Reserved